Antony A. Riley - Jul 31, 2023 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
Chief Financial Officer
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Stock symbol
FBRX
Transactions as of
Jul 31, 2023
Transactions value $
$149,999
Form type
4
Date filed
8/2/2023, 05:57 PM
Previous filing
Jul 5, 2023
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBRX Common Stock Award $150K +149K +525.49% $1.01 177K Jul 31, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,500 shares of Common Stock acquired July 3, 2023 under Forte Biosciences, Inc.'s 2017 Employee Stock Purchase Plan.